A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.
Mirum Pharmaceuticals MIRM announced that it has completed enrollment in the phase III AZURE-1 study, evaluating its pipeline candidate, brelovitug, for the treatment of chronic hepatitis delta virus ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...
Though Florida’s top medical official proclaimed last fall that the state would end all vaccine mandates for school children, six months later the Florida Legislature looks unlikely ...
State Rep. Becky Currie aims to review the inmate welfare fund and reduce prison deaths, among other reforms passed by the House. The Mississippi House of Representatives has inserted language from ...
The 12-week vaccine visit is a milestone most new parents dread a little. The baby gets several shots at once, and within hours the household can shift from calm to chaotic: low-grade fever, ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva® (obinutuzumab) in adults with systemic lupus ...
Swedish specialty pharma Orexo is reorganizing its management team as it pivots away from direct US commercialization ...
Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.